Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pascal Biscay"'
Autor:
Raphael Borie, Marie Pierre Debray, Alexis F. Guedon, Arsene Mekinian, Louis Terriou, Valentin Lacombe, Estibaliz Lazaro, Aurore Meyer, Alexis Mathian, Samuel Ardois, Guillaume Vial, Thomas Moulinet, Benjamin Terrier, Yvan Jamilloux, Mael Heiblig, Jean-David Bouaziz, Eve Zakine, Roderau Outh, Sylvie Groslerons, Adrien Bigot, Edouard Flamarion, Marie Kostine, Pierrick Henneton, Sebastien Humbert, Arnaud Constantin, Maxime Samson, Nadine Magy Bertrand, Pascal Biscay, Celine Dieval, Herve Lobbes, Juliette Jeannel, Amelie Servettaz, Leo Adelaide, Julie Graveleau, Benjamin de Sainte-Marie, Joris Galland, Vivien Guillotin, Eugénie Duroyon, Marie Templé, Rim Bourguiba, Sophie Georgin Lavialle, Olivier Kosmider, Alexandra Audemard-Verger, Julien Haroche, Zahir Amoura, Micheline Pha, Miguel Hie, Kilifa Meghit, Murielle Rondeau-Lutz, Jean-Christophe Weber
Publikováno v:
Chest. 163:575-585
The vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a newly identified autoinflammatory disorder related to somatic UBA1 mutations. Up to 72% of patients may show lung involvement.What are the pleuropulmonary manifestatio
Autor:
Marc Michel, Charlée Nardin, Nicolas Delanoy, Virginie Levrat, Jacques Vargaftig, Vincent Ribrag, Christine Mateus, Bertrand Godeau, Charlotte Leduc, Aurélien Marabelle, Laure Croisille, Olivier Lambotte, Patricia Pautier, Jean-Marie Michot, Romain Dupont, Aude Guillemin, Gilles Quere, Thibault Comont, Grégoire Marret, Marie Maerevoet, Caroline Robert, Jean-Christophe Bout, Stéphane Champiat, Pascal Biscay, Julien Lazarovici, Benjamin Besse, Charles Herbaux, Philippe Saiag, Salim Laghouati, Laurence Albiges, Christophe Massard, Anne-Laure Voisin, Cécile Dujon, Mikael Ebbo, Emanuela Madonna, Claude Chahine, Nora Kramkimel
Publikováno v:
The Lancet Haematology. 6:e48-e57
Summary Background Anti-programmed cell death 1 (PD-1) and anti-programmed cell death ligand 1 (PD-L1) antibodies are novel immunotherapies for cancer that can induce immune-related adverse events (irAEs). These adverse events can involve all organs,
Autor:
Pierre Duffau, Noémie Gensous, Marie-Elise Truchetet, Christophe Richez, Pascal Biscay, Thomas Barnetche, Estibaliz Lazaro, Mathilde Pugès, Julien Seneschal
Publikováno v:
Rheumatology. 55:1664-1672
The aim was to assess the immunogenicity and the impact on disease activity of pneumococcal and influenza vaccines in SLE patients.We conducted a systematic literature review and meta-analysis of studies comparing the humoral response of either pneum
Autor:
Grégoire Marret, Aude Guillemin, Cécile Dujon, Jacques Vargaftig, Christophe Massard, Anne-Laure Voisin, Laure Croisille, Claude Chahine, Olivier Lambotte, Vincent Ribrag, Aurélien Marabelle, Stéphane Champiat, Thibault Comont, Virginie Levrat, Laurence Albiges, Jean-Marie Michot, Charlée Nardin, Romain Dupont, Marie Maerevoet, Salim Laghouati, Nicolas Delanoy, Gilles Quere, Pascal Biscay, Charles Herbaux, Emmanuela Madonna, Mikael Ebbo, Bertrand Godeau, Julien Lazarovici, Christine Mateus, Patricia Pautier, Charlotte Leduc, Nora Kramkimel, Jean-Christophe Bout, Philippe Saiag, Benjamin Besse, Caroline Robert, Marc Michel
Publikováno v:
SSRN Electronic Journal.
Background. Anti-programmed death (ligand) 1 (PD-(L)1) antibodies are novel immunotherapies for cancer. Anti-PD(L)1 can induce immune-related adverse events (irAEs), which most frequently affect the skin, endocrine glands, lung, liver and digestive t
Autor:
Pascal Biscay, Aude Guillemin, Vincent Ribrag, Aurélien Marabelle, Julien Lazarovici, Virginie Levrat, Salim Laghouati, Stéphane Champiat, Patricia Pautier, Olivier Lambotte, Jean-Marie Michot, Marie Maerevoet, Cécile Dujon, Claude Chahine, Anne-Laure Voisin, Laure Croisille, Laurence Albiges, Christophe Nardin, Thibault Comont, Grégoire Marret, Gilles Quere, Benjamin Besse, Nora Kramkimel, Marc Michel, Charlotte Leduc, Christine Mateus, Emmanuela Madonna, Philippe Saiag, Romain Dupont, Mikael Ebbo, Nicolas Delanoy, Jean-Christophe Bout, Caroline Robert, Bertrand Godeau, Charles Herbaux, Christophe Massard
Publikováno v:
Blood. 132:2412-2412
Background. Anti-programmed death (ligand) 1 (PD-(L)1) antibodies are novel immunotherapies for cancer. Anti-PD(L)1 can induce immune-related adverse events (irAEs), which most frequently affect the skin, endocrine glands, lung, liver and digestive t